Pamela G. Coxson

机构：University of California, San Francisco · ORCID：0000-0001-8254-2660

发表论文 114 篇 · 总被引 7287 次 · h-index 36

代表论文

• Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease (2016 · JAMA · 被引 387)
• Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines (2015 · New England Journal of Medicine · 被引 242)
• Projected Impact of Mexico’s Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study (2016 · PLoS Medicine · 被引 208)
• Association of Low Socioeconomic Status With Premature Coronary Heart Disease in US Adults (2020 · JAMA Cardiology · 被引 185)
• Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial (2017 · JAMA · 被引 148)
• Cost-Effectiveness and Population Impact of Statins for Primary Prevention in Adults Aged 75 Years or Older in the United States (2015 · Annals of Internal Medicine · 被引 120)